Item 1.01 Entry into a Material Definitive Agreement.

On January 2, 2022, Silicon Laboratories Inc. (the "Company") entered into a First Supplemental Indenture, dated as of January 2, 2022 (the "Supplemental Indenture"), to the Indenture, dated as of June 1, 2020 (the "Indenture") between the Company and Wilmington Trust, National Association, as trustee, governing the Company's outstanding 0.625% Convertible Senior Notes due 2025 (the "Notes"). Pursuant to the Supplemental Indenture, the Company irrevocably elected: (i) to eliminate the Company's option to choose Physical Settlement (as defined in the Indenture) on any conversion of Notes that occurs on or after the date of the Supplemental Indenture; and (ii) that, with respect to any Combination Settlement (as defined in the Indenture) for a conversion of Notes, the Specified Dollar Amount (as defined in the Indenture) that will be settled in cash per $1,000 principal amount of the Notes shall be no lower than $1,000. The Indenture was filed as Exhibit 4.1 to the Company's Current Report on Form 8-K filed on June 1, 2020.

The foregoing description of the Supplemental Indenture does not purport to be complete and is qualified in its entirety by reference to the complete text of the Supplemental Indenture, a copy of which is filed as Exhibit 4.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



   4.1       First Supplemental Indenture between Silicon Laboratories Inc. and
           Wilmington Trust, National Association, as trustee, dated January 2,
           2022

104        Cover Page Interactive Data File (embedded within the Inline XBRL
           document)

© Edgar Online, source Glimpses